Molecules · 2019 · 88 citations · 39 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationInnate ImmunityAnti-inflammatory PharmacologyCytokine BiologyInflammatory Cell ResponsesInflammatory Cell SignalingInflammatory MediatorsInflammatory SignalingAnti-inflammatory ActivityAnticancer ActivityInflammatory Response GenesMapk SignalingNitric OxidePro-inflammatory Mediator ProductionPro-inflammatory Signaling PathwaysProstaglandin Production
Background: Polyphyllin VII (PP7), a steroidal saponin from Paris polyphylla, has been found to exert strong anticancer activity. Little is known about the anti-inflammatory property of PP7. In this study, the anti-inflammatory activity and its underlying mechanisms of PP7 were evaluated in lipopolysaccharide (LPS)-stimulated RAW264.7 cells and in multiple animal models. Methods: The content of nitric oxide (NO) was determined by spectrophotometry. The levels of prostaglandin E2 (PGE2) and cytokines were measured by enzyme-linked immunosorbent assay (ELISA) assay. The mRNA expression of pro-inflammatory genes was determined by qPCR. The total and phosphorylated protein levels were examined by Western blotting. The in vivo anti-inflammatory activities were evaluated by using mouse and zebrafish models. Results: PP7 reduced the production of NO and PGE2 and the protein and mRNA expressions of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and enzymes (inducible NO synthase [iNOS], cyclooxygenase-2 [COX-2], and Matrix metalloproteinase-9 [MMP-9]) in LPS-induced RAW264.7 cells by suppressing the NF-κB and MAPKs pathways. Notably, PP7 markedly inhibited xylene-induced ear edema and cotton pellet-induced granuloma formation in mice and suppressed LPS and CuSO4-induced inflammation and toxicity in zebrafish embryos. Conclusion: This study demonstrates that PP7 exerts strong anti-inflammatory activities in multiple in vitro and in vivo models and suggests that PP7 is a potential novel therapeutic agent for inflammatory diseases.
39
Activators and target genes of Rel/NF-κB transcription factors
Heike L. Pahl · Oncogene · 1999 · 3.7K citations
A transgenic zebrafish model of neutrophilic inflammation
Stephen A. Renshaw, Catherine A. Loynes, Daniel M.I. Trushell et al. · Blood · 2006 · 1K citations · Full text
Tumor necrosis factors: developments during the last decade.
B B Aggarwal, Kasthuri Natarajan · PubMed · 1996 · 469 citations
Life Sciences, Immunology, Oncology +14